Low grade fibromyxoid sarcoma: problems in the diagnosis and management of a malignant tumour with bland histological appearance

References

• Evans H L. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol 1987; 88: 615–619
   PubMed Web of Science ®Google Scholar
• Evans H L. Low-grade fibromyxoid sarcoma: a report of 12 cases. Am J Surg Pathol 1993; 17: 595–600
   PubMed Web of Science ®Google Scholar
• Goodlad J R, Mentzel T, Fletcher C DM. Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity. Histoathology 1995; 26: 229–237
   PubMed Web of Science ®Google Scholar
• Lane K L, Shannon R J, Weiss S W. Hyalinising spindle cell tumour with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am J Surg Pathol 1997; 21: 1481–1488
   PubMed Web of Science ®Google Scholar
• Berjarno P A, Padhya T A, Smith R, et al. Hyalinising spindle cell tumor with giant rosettes-a soft tissue tumor with mesenchymal and neuroendocrine features: an immunohistochemical, ultrastructural and cytogenetic analysis. Arch Pathol Lab Med 2000; 124: 1179–1184
   PubMed Web of Science ®Google Scholar
• Reid R, de Silva M V, Paterson L, et al. Low grade fibromyxoid sarcoma and hyalinsing spindle cell tumour with giant rosettes share a common t(7; 16)(q34; p11) translocation. Am J Surg Pathol 2003; 27: 1229–1236
   PubMed Web of Science ®Google Scholar
• Storlazzi C T, Mertens F, Nascimento A, et al. Fusion of the FUS and BBF2H7 genes in low grade fibromyxiod sarcoma. Hum Mol Genet 2003; 12: 2349–2358
   PubMed Web of Science ®Google Scholar
• Panagopoulos I, Storlazzi C T, Fletcher C DM, et al. The chimeric FUS/CREB3L2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer 2004; 40: 218–228
   PubMed Web of Science ®Google Scholar
• Mertens F, Fletcher C DM, Antonescu C R, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest 2005; 85: 408–415
   PubMed Web of Science ®Google Scholar
• Matsuyama A, Hisaoka M, Shimajiri S, et al. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Am J Surg Pathol 2006; 30: 1077–1084
   PubMed Web of Science ®Google Scholar
• Folpe A L, Lane K L, Paull G, et al. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol 2000; 24: 1353–1360
   PubMed Web of Science ®Google Scholar
• Billings S D, Giblen G, Fanburg-Smith J C. Superficial low-grade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol 2005; 29: 204–210
   PubMed Web of Science ®Google Scholar
• Schaffer L G, Tommerup N. ICSN 2005: An International System for Human Cytogenetic Nomenclature. S Karger, Basel 2005
   Google Scholar
• Hornick J L, Fletcher C D. Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features. Am J Surg Pathol 2005; 29: 845–858
   PubMed Web of Science ®Google Scholar
• Folpe A L, Billings S D, McKenney J K, et al. Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics. Am J Surg Pathol 2002; 26: 1620–1626
   PubMed Web of Science ®Google Scholar
• Kempson R L, Fletcher C D, Evans H L, et al. Tumors of the Soft Tissues. Atlas of Tumor Pathology, Series 3, Fascicle 30. Armed Forces Institute of Pathology, Washington, DC 2001; 52–55
   Google Scholar
• Bhattacharya B, Dilworth H P, Iacobuzio-Donahue C, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005; 29: 653–659
   PubMed Web of Science ®Google Scholar
• Downs-Kelly E, Goldblum J R, Patel R M, et al. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms. Am J Surg Pathol 2008; 32: 8–13
   PubMed Web of Science ®Google Scholar
• Rossi S, Szuhai K, Ijszenga M, et al. EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res 2007; 13: 7322–7328
   PubMed Web of Science ®Google Scholar
• Choi H W, Shin M G, Sawyer J R, et al. Unusual type of TLS/FUS-ERG chimeric transcript in a pediatric acute myelocytic leukaemia with 47,XX, + 10,t(16;21)(p11;q22). Cancer Genet Cytogenet 2006; 167: 172–176
   PubMed Web of Science ®Google Scholar
• Kanazawa T, Ogawa C, Taketani T, et al. TLS/FUS-ERG fusion gene in acute lymphoblastic leukaemia with t(16;21)(p11;q22) and monitoring of minimal residual disease. Leuk Lymphoma 2005; 46: 1833–1835
   PubMed Web of Science ®Google Scholar
• Ng T L, O'Sullivan M J, Pallen C J, et al. Ewing sarcoma with novel translocation t(2; 16) producing an in-frame fusion of FUS and FEV. J Mol Diagn 2007; 9: 459–463
   PubMed Web of Science ®Google Scholar